Literature DB >> 1437512

Catecholamines in critical care. The commonly used catecholamines: receptor and clinical profile, indications and dosages.

F W Santman1.   

Abstract

The pharmacology, pattern of receptor activation and resulting clinical impact of the currently most widely used intravenous catecholamines are reviewed. A brief physiological description of the alpha, beta and dopaminergic receptors is used in order to explain the clinical effects of norepinephrine, epinephrine, isoproterenol, dopamine, dobutamine and dopexamine. Each drug is discussed separately according to receptor profile, indications, dosages and current application in critical care. Tables are provided for comparison of relative strengths of these drugs regarding receptor activation, haemodynamic effects, organ perfusion and recommended dosages. The use of combinations of catecholamines to meet a variety of circulatory demands is commented upon.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437512     DOI: 10.1007/bf01977616

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  53 in total

1.  Renal-dose dopamine: fact and fiction.

Authors:  H M Szerlip
Journal:  Ann Intern Med       Date:  1991-07-15       Impact factor: 25.391

2.  The availability of 10 mg epinephrine vials for cardiac arrest: a retrospective analysis. The Belgian Cerebral Resuscitation Study Group.

Authors:  P R Martens; A Mullie
Journal:  Resuscitation       Date:  1991-12       Impact factor: 5.262

3.  Accuracy of intracardiac injections determined by a post-mortem study.

Authors:  H I Sabin; S B Coghill; K Khunti; G O McNeill
Journal:  Lancet       Date:  1983-11-05       Impact factor: 79.321

4.  Sympathomimetic amines: potential clinical applications in ischemic heart disease.

Authors:  L I Goldberg; S I Rajfer
Journal:  Am Heart J       Date:  1982-04       Impact factor: 4.749

5.  Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors.

Authors:  R A Brown; J Dixon; J B Farmer; J C Hall; R G Humphries; F Ince; S E O'Connor; W T Simpson; G W Smith
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

6.  Reversal of intractable septic shock with norepinephrine therapy.

Authors:  D Meadows; J D Edwards; R G Wilkins; P Nightingale
Journal:  Crit Care Med       Date:  1988-07       Impact factor: 7.598

7.  Treatment of cardiac and renal effects of PEEP with dopamine in patients with acute respiratory failure.

Authors:  M Hemmer; P M Suter
Journal:  Anesthesiology       Date:  1979-05       Impact factor: 7.892

8.  Inotropic response of the neonatal canine myocardium to dopamine.

Authors:  D J Driscoll; P C Gillette; E G Ezrailson; A Schwartz
Journal:  Pediatr Res       Date:  1978-01       Impact factor: 3.756

9.  Redistribution of pulmonary blood flow induced by positive end-expiratory pressure and dopamine infusion in acute respiratory failure.

Authors:  D Matamis; F Lemaire; A Harf; B Teisseire; C Brun-Buisson
Journal:  Am Rev Respir Dis       Date:  1984-01

10.  Alpha and beta adrenergic effects of the stereoisomers of dobutamine.

Authors:  R R Ruffolo; T A Spradlin; G D Pollock; J E Waddell; P J Murphy
Journal:  J Pharmacol Exp Ther       Date:  1981-11       Impact factor: 4.030

View more
  1 in total

1.  A physiological model for autonomic heart rate regulation in human endotoxemia.

Authors:  Panagiota T Foteinou; Steve E Calvano; Stephen F Lowry; Ioannis P Androulakis
Journal:  Shock       Date:  2011-03       Impact factor: 3.454

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.